Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

IMMUNODEFICIENCY FOUNDATION — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report

IMMUNODEFICIENCY FOUNDATION

via HART HEALTH STRATEGIES

2nd Quarter (Apr 1 - June 30) · 2012Posted Jul 16, 2012Filing document ↗LDA record ↗

Income$40Kfee reported

Client

Name: IMMUNODEFICIENCY FOUNDATION
Location: * Undetermined

Registrant

Firm: HART HEALTH STRATEGIES
Description: Healthcare Consulting Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Monitoring health care regulations and legislation
LobbyistsVICKI HART · SUSAN RAMTHUN · TIMOTHY YEHL
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.